Pharma IQ is proudly announcing a new speaker on board, professor Chris Jennison of the University of Bath. Professor Jennison will join our speaker panel evaluating innovations in clinical trial design at the Innovation in Clinical Design, Analysis and Reporting conference in London, 7th-8th of December 2010.
Professor Chris Jennison will survey statistical methods for the design, monitoring and adaptation of clinical trials. He will introduce group sequential ‘error spending’ tests that offer flexibility to deal with fluctuations in patient accrual or response rates and the uncertainties of survival data. He will present adaptive methods and discuss their application in: sample size re-estimation, refining the patient population in ‘enrichment’ designs, and selecting the treatment or dose level to take forward to the second stage of a combined Phase II/III trial.
Question for Liz include:
Leading multilingual search marketing news site 
